/CNW/ - BluEnergies Ltd. (TSXV: BLU) ("Blu" or the "Company"), announces that Mr. Craig Steinke has been appointed Chief Executive Officer ("CEO") and as a...
/CNW/ - BluEnergies Ltd. (formerly Acme Gold Company Limited) ("BluEnergies" or the "Company") (TSXV: BLU) is pleased to announce that it has received final...
/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“ BELLUS Health ” or the “ Company ”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough,...
Biotech is expected to be a hotbed of mergers and acquisitions this year.
The British drugmaker picked up a potential blockbuster drug in its deal for Bellus Health.
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
A wave of bargain buying benefited the gene therapy company's shares this week.
The company has received a buyout offer from GSK.